Racheli Ofir
Chief Executive Officer en Betalin Therapeutics Ltd. .
Perfil
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd.
Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Cargos activos de Racheli Ofir
| Empresas | Cargo | Inicio |
|---|---|---|
Betalin Therapeutics Ltd.
 Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Chief Executive Officer | 01/12/2022 |
Antiguos cargos conocidos de Racheli Ofir.
| Empresas | Cargo | Fin |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formación de Racheli Ofir.
| Technion-Israel Institute of Technology | Doctorate Degree |
| Israel Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Technology Services |
- Bolsa de valores
- Insiders
- Racheli Ofir
